Our Team
Our Team
OBRI is led by a dedicated team of researchers, clinicians, and patients working together to advance real-world arthritis research.
Research Team

Dr. Bindee Kuriya
MD, MSc, FRCPC
Principal Investigator
University Health Network / University of Toronto
Dr. Bindee Kuriya is a rheumatologist and clinician-scientist at the University Health Network and University of Toronto. She leads the Ontario Best Practices Research Initiative (OBRI), focusing on real-world outcomes research in rheumatoid arthritis and advancing evidence-based care for arthritis patients across Canada.

Dr. Mohammad Movahedi
M.D., Ph.D.
Senior Epidemiologist / Research Scientist
University Health Network
Dr. Movahedi is a Senior Research Scientist and Epidemiologist at OBRI with a background in medicine. His expertise includes real-world evidence research, administrative health databases, and longitudinal cohort studies in rheumatology, with a focus on evaluating treatment effectiveness, safety, and patient outcomes.

Angela Cesta
MSc, CCRP
OBRI Clinical Research Manager
University Health Network
Angela Cesta is the OBRI Research Manager with extensive experience in registry operations, research ethics, data management, and clinical research in inflammatory arthritis. She leads the day-to-day management of OBRI research programs and supports collaborative initiatives aimed at advancing real-world evidence and improving patient outcomes in rheumatology.
Dr. Claire Bombardier
MD, FRCPC, MSc
Founder & Emeritus Investigator
University Health Network / University of Toronto
Dr. Bombardier is a rheumatologist and clinical epidemiologist who founded OBRI in 2005 and led the initiative for nearly two decades. Her research has shaped provincial drug policy and clinical guidelines for arthritis care across Canada.
Research Interviewers
OBRI Research Interviewers are integral to the success of the registry, ensuring that patient-reported data are collected accurately and consistently. Through regular contact with participants, they support longitudinal follow-up, maintain data quality, and help capture the patient experience over time.

Andrea McClintock

Lynda Linderman
Clinical Advisory Committee
The CAC is composed of rheumatologists and clinical experts who provide scientific guidance to the OBRI research team.

Dr. Bindee Kuriya
Principal Investigator

Dr. Arthur Lau

Dr. Sibel Aydin

Dr. Andrew Chow

Dr. Carter Thorne

Dr. Janet Pope

Ms. Cathie Hoffstetter

Dr. Pooneh Akhavan

Dr. Timothy Kwok

Dr. Reza Mirza
Patient Advisory Committee
The OBRI-RA Patient Advisory Committee (PAC) is a volunteer-led group comprised of patient representatives with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The PAC works to improve patient well-being through the promotion of rights detailed in the Canadian Arthritis Patients Charter. The OBRI PAC provides guidance to the OBRI research team through the communication of patient perspectives to research staff, students, investigators and other stakeholders; priority setting, project planning, and decision making; patient engagement, communication, and retention activities; and the dissemination of research/knowledge to patients and caregivers.

Catherine Hofstetter
PAC Chair

David Barker

Jennifer Boyle

Lynda Liderman

Erinn McQueen

Denis Morrice
